Status In progress
Technology type Device
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Description Bed frames (bed without the mattress) are used in a wide range of clinical and care settings. This assessment will focus on bed frames for use in acute care settings. There are many essential characteristics for bed frames, including no sharp edges, height adjustment, a setting for use during cardiopulmonary resuscitation, and compatibility with different types of mattresses. Acute bed frames have additional requirements, such as the facility to attach accessories, a cardiac chair position facility and specified side rails. Bed design features can support healthcare workers with tasks such as transportation and repositioning of patients. They can also help keep patients in an optimal position to aid recovery and reduce the risk of pressure ulcers. Some designs may help improve decontamination procedures for better infection control. Innovative patient safety features in care settings may include bed exit alarms and under-bed anti-entrapment sensors. Technologies in widespread or established use in the NHS often undergo continuous improvement or incremental innovation, leading to price variation. This NICE assessment aims to support commissioning and procurement decisions by assessing if the value added by incremental innovation justifies the price variation.

Provisional Schedule

Draft guidance 29 April 2025 - 14 May 2025
Committee meeting: 3 19 June 2025
Expected publication 19 August 2025

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
20 March 2025 Committee meeting: 2
16 January 2025 Following on from the Advisory committee meeting on the 19 December 2024 for Bed frames for adults in acute settings, the committee has considered the written and verbal evidence and has requested additional information be collected, before guidance is drafted. Therefore, no draft guidance will be released at this point. The above timeline has been amended to reflect this change.
19 December 2024 Committee meeting: 1
26 September 2024 Final scope
26 July 2024 In progress. Topic launch.
10 July 2024 Awaiting development. Status change linked to Topic Selection Decision being set to Selected